Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPlatform version updated from v3.5.2 to v3.5.3; this is a site-wide revision rather than a modification to the study content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded the MeSH term Mucopolysaccharidosis, MPS-I-H/S and an external resource link to the Genetic and Rare Diseases Information Center on the study page.SummaryDifference0.2%

- Check50 days agoChange DetectedHurler-Scheie syndrome and the Genetic and Rare Diseases Information Center resource were removed, reducing disease-specific context and external reference points for the study.SummaryDifference0.2%

- Check57 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0, indicating a frontend version upgrade without changes to the study details or eligibility.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.